Clicky

ChemoMetec A/S(CHY)

Description: ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCounter SP-100, an automated sperm cell counter for use in animal reproduction; and XcytoMatic 40, a cell density and viability analyzer. In addition, the company provides consumables comprising cassettes, reagents, lysis, and slides; accessories, which include cables, power supplies, software, and labware products, as well as service and validation plans and training. Further, it develops as well as develops XcytoMatic 30 cell counter. ChemoMetec A/S was incorporated in 1997 and is headquartered in Allerød, Denmark.


Keywords: Pharmaceutical Cancer Gene Therapy Cell Biology Laboratory Techniques Blood Test T Cell Flow Cytometry Clinical Pathology Analytical Equipment Sperm Cell Counting Labware Products

Home Page: chemometec.com

Gydevang 43
Allerød, 3450
Denmark
Phone: 45 48 13 10 20


Officers

Name Title
Mr. Martin Helbo Behrens CEO & COO
Mr. Hans Martin Glensbjerg Deputy Chairman & Senior Advisor
Mr. Kim Nicolajsen Chief Financial Officer
Mr. Christopher Runchel M.Sc., Ph.D. Chief Sales Officer
Marta Anglada Planaguma Chief Marketing & Strategy Officer
Ms. Lisbet Helles Head of Marketing
Mr. Søren Kjærulff Head of R&D
Mr. Bo Melholt Nielsen Chief R&D Officer and Physicist & Project Manager

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 0
Trailing PE: 61.3333
Price-to-Book MRQ: 14.7858
Price-to-Sales TTM: 2.7745
IPO Date:
Fiscal Year End: June
Full Time Employees: 174
Back to stocks